--- title: "Alebund Pharmaceuticals (Jiangsu) (9637) stock" url: "https://aibio.space/companies/alebund-pharmaceuticals-jiangsu/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Alebund Pharmaceuticals (Jiangsu) Limited (HKEX: 9637), China. The directory classifies it as Biotechnology." --- 9637 Alebund Pharmaceuticals (Jiangsu) Limited HKEX · China # Alebund Pharmaceuticals (Jiangsu) (9637) news Alebund Pharmaceuticals (Jiangsu) Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 9637, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Alebund Pharmaceuticals (Jiangsu) news We have not published a story on Alebund Pharmaceuticals (Jiangsu) yet. When there is news, it will appear here. ## Alebund Pharmaceuticals (Jiangsu) at a glance - **Ticker**: 9637 - **Listing**: HKEX - **Country**: China ### Related companies - [Shanghai RAAS Blood Products Co.](https://aibio.space/companies/shanghai-raas-blood-products/) SZSE: 002252 - [Zhejiang Hengtong Holding Co.](https://aibio.space/companies/zhejiang-hengtong/) SSE: 600226 - [LongBio Pharma (Suzhou) Co.](https://aibio.space/companies/longbio-pharma-suzhou/) HKEX: 1779 - [Guangdong Vtr Bio-Tech Co.](https://aibio.space/companies/guangdong-vtr-bio-tech/) SZSE: 300381 - [Shaanxi Micot Pharmaceutical Technology Co.](https://aibio.space/companies/shaanxi-micot-pharmaceutical-technology/) HKEX: 2335 - [Getein Biotech](https://aibio.space/companies/getein-biotech/) SSE: 603387 - [Jiangxi Institute of Biological Products](https://aibio.space/companies/jiangxi-institute-of-biological-products/) HKEX: 6915 - [Xiamen Amoytop Biotech Co.](https://aibio.space/companies/xiamen-amoytop-biotech/) SSE: 688278 ### Also on HKEX - [Zhongzhi Pharmaceutical Holdings](https://aibio.space/companies/zhongzhi-pharmaceutical/) 3737 - [Hygeia Healthcare Holdings Co.](https://aibio.space/companies/hygeia-healthcare/) 6078 - [CStone Pharmaceuticals](https://aibio.space/companies/cstone-pharmaceuticals/) 2616 - [Beijing Biostar Pharmaceuticals Co.](https://aibio.space/companies/beijing-biostar-pharmaceuticals/) 2563 - [Duality Biotherapeutics](https://aibio.space/companies/duality-biotherapeutics/) 9606 - [Lepu Biopharma Co.](https://aibio.space/companies/lepu-biopharma/) 2157 ## Questions about Alebund Pharmaceuticals (Jiangsu) What is the ticker symbol of Alebund Pharmaceuticals (Jiangsu)? Alebund Pharmaceuticals (Jiangsu) Limited trades under the ticker 9637 on HKEX. Where is Alebund Pharmaceuticals (Jiangsu) listed? Alebund Pharmaceuticals (Jiangsu) Limited is listed on HKEX. Which country or territory is Alebund Pharmaceuticals (Jiangsu) listed under? Our directory records Alebund Pharmaceuticals (Jiangsu) Limited under China. What does Alebund Pharmaceuticals (Jiangsu) do? Our directory classifies Alebund Pharmaceuticals (Jiangsu) Limited as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of Alebund Pharmaceuticals (Jiangsu)? The ISIN recorded for Alebund Pharmaceuticals (Jiangsu) Limited is CNE100007QD0. Does aibio.space cover Alebund Pharmaceuticals (Jiangsu)? aibio.space lists Alebund Pharmaceuticals (Jiangsu) Limited among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to Alebund Pharmaceuticals (Jiangsu)? Companies in our directory listed in the same country and business area as Alebund Pharmaceuticals (Jiangsu): Shanghai RAAS Blood Products Co., Zhejiang Hengtong Holding Co., LongBio Pharma (Suzhou) Co., Guangdong Vtr Bio-Tech Co., Shaanxi Micot Pharmaceutical Technology Co., Getein Biotech. ## Investor discussion: Alebund Pharmaceuticals (Jiangsu) Members talk about Alebund Pharmaceuticals (Jiangsu) (9637). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Alebund Pharmaceuticals (Jiangsu), newest first. Each line links the filing it comes from. 1. 2026-07-24 Financings Share or debt issue: (1) PROPOSED APPOINTMENT OF AUDITOR (2) PROPOSED GRANTING OF GENERAL MANDATE TO ISSUE SHARES (3) PROPOSED GRANTING OF GENERAL MANDATE TO REPURCHASE H SHARES AND (4) NOTICE OF THE EXTRAORDINARY GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0724/2026072401842.pdf) 2. 2026-06-17 Financings Share or debt issue: GLOBAL OFFERING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0618/2026061800025.pdf) ## Press releases Headlines of Alebund Pharmaceuticals (Jiangsu)'s own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-10-20 HKEXnews [VOLUNTARY ANNOUNCEMENT - ON-MARKET SHARE REPURCHASE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1020/2026102001237.pdf) 2. 2026-09-08 HKEXnews [VOLUNTARY ANNOUNCEMENT - INVESTIGATIONAL NEW DRUG APPLICATION FOR AP308 FOR THE TREATMENT OF IgA NEPHROPATHY CLEARED BY THE U.S. FOOD AND DRUG ADMINISTRATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0908/2026090800987.pdf) 3. 2026-09-04 HKEXnews [VOLUNTARY ANNOUNCEMENT - INCLUSION IN THE LIST OF ELIGIBLE SECURITIES FOR SOUTHBOUND TRADING UNDER STOCK CONNECT AND IN THE HANG SENG COMPOSITE INDEX](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0904/2026090402361.pdf) 4. 2026-08-26 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0826/2026082600779.pdf) 5. 2026-08-14 HKEXnews [POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON FRIDAY, AUGUST 14, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0814/2026081401185.pdf) 6. 2026-08-07 HKEXnews [VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION FOR AP301 CAPSULES FOR THE TREATMENT OF HYPERPHOSPHATEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE RECEIVING DIALYSIS ACCEPTED FOR REVIEW BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF CHINA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0807/2026080700640.pdf) 7. 2026-08-06 HKEXnews [POSITIVE PROFIT ALERT FOR THE SIX MONTHS ENDED JUNE 30, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0806/2026080600624.pdf) 8. 2026-07-29 HKEXnews [Articles of Association](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0729/2026072901521.pdf) 9. 2026-07-29 HKEXnews [AMENDMENTS TO THE ARTICLES OF ASSOCIATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0729/2026072901511.pdf) 10. 2026-07-24 HKEXnews [NOTICE OF EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0724/2026072401860.pdf) 11. 2026-07-24 HKEXnews [(1) PROPOSED APPOINTMENT OF AUDITOR (2) PROPOSED GRANTING OF GENERAL MANDATE TO ISSUE SHARES (3) PROPOSED GRANTING OF GENERAL MANDATE TO REPURCHASE H SHARES AND (4) NOTICE OF THE EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0724/2026072401842.pdf) 12. 2026-07-24 HKEXnews [FULL EXERCISE OF THE OVER-ALLOTMENT OPTION, STABILIZING ACTIONS AND END OF STABILIZATION PERIOD](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0724/2026072400262.pdf) 13. 2026-07-22 HKEXnews [Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0722/2026072200576.pdf) 14. 2026-07-22 HKEXnews [Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0722/2026072200552.pdf) 15. 2026-07-21 HKEXnews [VOLUNTARY ANNOUNCEMENT FIRST PARTICIPANT RANDOMIZED AND DOSED IN GLOBAL PHASE IIb MULTI-REGIONAL CLINICAL TRIAL OF AP306 FOR HYPERPHOSPHATEMIA IN PATIENTS RECEIVING MAINTENANCE HEMODIALYSIS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0721/2026072100979.pdf) 16. 2026-06-26 HKEXnews [ANNOUNCEMENT OF FINAL OFFER PRICE AND ALLOTMENT RESULTS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0626/2026062603033.pdf) 17. 2026-06-25 HKEXnews [Terms of Reference of the Strategy Committee](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0626/2026062600057.pdf) 18. 2026-06-25 HKEXnews [Terms of Reference for the Nomination Committee of the Board of Directors](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0626/2026062600053.pdf) 19. 2026-06-25 HKEXnews [Terms of Reference for the Remuneration and Appraisal Committee of the Board of Directors](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0626/2026062600041.pdf) 20. 2026-06-25 HKEXnews [Terms of Reference for the Audit Committee of the Board of Directors](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0626/2026062600031.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:9637 on TradingView](https://www.tradingview.com/symbols/HKEX-9637/). ## Listing details Alebund Pharmaceuticals (Jiangsu) Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 9637, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Alebund Pharmaceuticals (Jiangsu) Limited - **Ticker**: 9637 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Biotechnology - **ISIN**: CNE100007QD0 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-9637/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/alebund-pharmaceuticals-jiangsu/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Alebund Pharmaceuticals (Jiangsu) (9637) stock", 2026-10-31, https://aibio.space/companies/alebund-pharmaceuticals-jiangsu/